- Home
- SMTI vs AVIR Comparison
SMTI vs AVIR Comparison
Compare SMTI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- AVIR
- Stock Information
- Founded
- SMTI 1982
- AVIR 2012
- Country
- SMTI United States
- AVIR United States
- Employees
- SMTI N/A
- AVIR N/A
- Industry
- SMTI Medical/Dental Instruments
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- SMTI Health Care
- AVIR Health Care
- Exchange
- SMTI Nasdaq
- AVIR Nasdaq
- Market Cap
- SMTI 252.1M
- AVIR 273.0M
- IPO Year
- SMTI N/A
- AVIR 2020
- Fundamental
- Price
- SMTI $29.65
- AVIR $3.74
- Analyst Decision
- SMTI Strong Buy
- AVIR Hold
- Analyst Count
- SMTI 2
- AVIR 1
- Target Price
- SMTI $49.50
- AVIR $6.00
- AVG Volume (30 Days)
- SMTI 45.1K
- AVIR 413.9K
- Earning Date
- SMTI 08-11-2025
- AVIR 08-06-2025
- Dividend Yield
- SMTI N/A
- AVIR N/A
- EPS Growth
- SMTI N/A
- AVIR N/A
- EPS
- SMTI N/A
- AVIR N/A
- Revenue
- SMTI $91,569,883.00
- AVIR N/A
- Revenue This Year
- SMTI $23.53
- AVIR N/A
- Revenue Next Year
- SMTI $5.93
- AVIR N/A
- P/E Ratio
- SMTI N/A
- AVIR N/A
- Revenue Growth
- SMTI 34.65
- AVIR N/A
- 52 Week Low
- SMTI $25.86
- AVIR $2.46
- 52 Week High
- SMTI $39.08
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- SMTI 54.56
- AVIR 75.75
- Support Level
- SMTI $28.00
- AVIR $3.43
- Resistance Level
- SMTI $30.59
- AVIR $3.80
- Average True Range (ATR)
- SMTI 1.22
- AVIR 0.14
- MACD
- SMTI 0.27
- AVIR 0.03
- Stochastic Oscillator
- SMTI 74.93
- AVIR 78.46
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).